Organon: A Look Beyond The Dividend Cut

Organon & Co. (NYSE: OGN ), which spun off from Merck & Co. ( MRK ) in June 2021, is a global healthcare company with over 70 medicines and products in its portfolio. Since its spin-off, the company’s stock price has been witnessingI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My inve ...